Scientific Advisory Board

The Institute's Scientific Advisory Board

To ensure a high quality of research is maintained over the long term, all Max Planck Institutes are subject to regular assessment from independent advisory boards. The board members, experts from leading international research institutions and universities, are selected by the president of the Max Planck Society on the basis of suggestions from the institutes. The are elected to the board for a maximum term of six years.


The Scientific Advisory Board of the Max Planck Institute for Biophysical Chemistry is currently composed of 16 members:

  • Prof. Dr. Mike Ashfold
    School of Chemistry, University of Bristol, UK
     
  • Prof. Dr. Hugo J. Bellen, 
    Baylor College of Medicine, Howard Hughes Medical Institute, Houston, USA
     
  • Prof. Dr. Carmen Birchmeier-Kohler, 
    Max-Delbrück-Centrum für Molekulare Medizin, Berlin
     
  • Prof. Dr. Sir David A. Case, 
    BioMaPS Institute and Department of Chemistry & Chemical Biology, Rutgers University, Piscataway, USA
        
  • Prof. Dr. Susan M. Gasser, 
    Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland
     
  • Prof. Dr. Ari Helenius, 
    Institut für Biochemie, ETH Zürich, Switzerland
     
  • Prof. Dr. Peter Jonas, 
    Institute of Science and Technology Austria, Klosterneuburg, Austria
     
  • Prof. Dr. Steve A. Kay, 
    USC Dana and David Dornsife, College of Letters, Arts and Sciences, Los Angeles, USA
     
  • Prof. Dr. Michael Levitt, 
    Department of Structural Biology, Stanford University School of Medicine, Stanford, USA
        
  • Prof. Dr. David Nesbitt, 
    Department of Chemistry and Biochemistry, University of Colorado at Boulder, Boulder, USA
     
  • Prof. Dr. Mark S. P. Sansom, 
    Department of Biochemistry University of Oxford, Oxford, UK
     
  • Prof. Dr. Antonio Simeone, 
    CEINGE, Naples, Italy
     
  • Prof. Dr. Sir Peter So, 
    Massachusetts Institute of Technology, Dept. of Mechanical Engineering, Cambridge, USA 
     
  • Prof. Dr. Thomas A. Steitz, 
    Dept. Molecular Biophysics and Biochemistry, Yale University, New Haven, USA
        
  • Prof. Dr. Joseph S. Takahashi, 
    Howard Hughes Medical Institute, University of Texas, USA
        
  • Prof. Dr. Xiaoliang Sunney Xie, 
    Department of Chemistry and Chemical Biology, Harvard University, Cambridge, USA
     

 

 
loading content